Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...

A large study out of Singapore that examined 84 commonly used supplements found that, on average, people who took supplements ...

PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL ...

Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are ...

Antimicrobial resistance is a global threat to public health, already associated with more than 1 million attributable deaths per year; Enterobacterales, including Escherichia coli, are the pathogens ...

Lung transplant for stage IV lung cancer achieved 100% one-year survival in 17 NSCLC patients in a landmark JAMA study from ...

Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...

A wave of cannabis-related research published in 2026 has examined the plant’s potential impact on pain, cancer, neurological ...

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

A systematic review and meta-analysis of 8 observational studies found that greater obstructive sleep apnea severity was ...

Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants ...

AVE has made a breakthrough in a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness.